Wacker et al. report the crystal structure of LSD in complex with one of its major targets in the brain, the 5-HT 2B receptor, the first such structure for any psychedelic drug. The results shed light on the molecular mechanisms underlying its ability to induce hallucinations with greater duration and potency than closely related compounds.
Wacker et al. report the crystal structure of LSD in complex with one of its major targets in the brain, the 5-HT 2B receptor, the first such structure for any psychedelic drug. The results shed light on the molecular mechanisms underlying its ability to induce hallucinations with greater duration and potency than closely related compounds.
Lysergic acid diethylamide (LSD), also known as ''acid,'' is one of the most potent psychedelic drugs. At low-microgram dosages, LSD can cause hallucinations (alteration of perception, emotion, and cognition), or ''trips,'' that last for up to 15 hr. Albert Hofmann first synthesized LSD in 1938, but its psychedelic effects were only discovered five years later, when he accidentally exposed himself to trace amounts, resulting in a ''not-unpleasant'' condition characterized by an ''extremely stimulated imagination'' along with an ''uninterrupted stream of fantastic pictures.'' He later confirmed that LSD was the culprit by self-administering 250 mg, now considered a heavy dose, and experienced the world's first intentional acid trip in part while bicycling home from his lab (Hofmann, 1979) . LSD gained popularity in early '60s for recreational use but later became regulated as a type I substance. Use of LSD resurged in the middle '90s in the United States when, according to the Monitoring the Future study, 8.8% of 12 th grade students reported that they had used LSD at least once. The percentage has declined to 2% since 2002, presumably due to enhanced control over LSD precursors (Johnston et al., 2016) . LSD has come to attention more recently because it shows promise for treating alcohol abuse and depression and in alleviating the anxiety of patients suffering terminally ill diseases. Although the drug targets a broad spectrum of receptors in vivo, it is believed to exert its psychedelic effects primarily by binding to the 5-HT 2A serotonin receptor (Titeler et al., 1988) , a G-protein-coupled receptor. However, the molecular mechanisms underlying its potent psychedelic effect have remained elusive. In this issue of Cell, Wacker et al. (2017) now report the crystal structure of LSD in complex with the closely related 5-HT 2B receptor. The study establishes that LSD induces unique conformational changes in the receptor that likely underlie its psychedelic activity and sheds light on the structural basis for the high potency of LSD and the long duration of its effects ( Figure 1 ). An intriguing question in the field is why LSD leads to hallucination, while chemically similar 5-hydroxytryptamine (5-HT) receptor agonists do not. The phenomenon of different ligands targeting the same receptor but leading to different functional outcomes is known as biased signaling (Violin and Lefkowitz, 2007) , or functional selectivity (Urban et al., 2007) . Biased signaling can occur if each ligand stabilizes the receptor in a unique conformational state that differentially engages downstream signaling partners. In the case of 5-HT receptors, the best understood downstream partners are heterotrimeric G proteins and scaffolding proteins known as arrestins. The psychedelic effect of LSD relative to less-hallucinogenic analogs like lysergamide could be a consequence of bias toward arrestin recruitment, as suggested by the fact that LSD-bound 5-HT 2A and 5-HT 2B is 100-fold more efficient in recruiting arrestin than in activating G proteins (Wacker et al., 2013) . In Wacker et al. (2017) , the authors suggest that the structure of the 5-HT 2B receptor in complex with LSD exhibits hallmarks of an arrestin-biased conformation because of its overall similarity to a prior structure of the 5-HT 2B receptor in complex with ergotamine (Wacker et al., 2013) , which is a nearly fully arrestinbiased ligand (but non-hallucinogenic because it cannot pass the blood-brain barrier). The authors, however, observe significant conformational differences in extracellular regions of the receptor that bind to LSD, which are likely coupled allosterically to conformational changes in the intracellular domain responsible for engaging G proteins and arrestins. The extent of these allosteric changes and how the ligand binding site couples to the intracellular domain remains to be fully understood, in part because the experimental approach used required extensive engineering of the receptor (e.g., introduction of a thermal stabilizing mutation and replacement of an intracellular loop with a rigid domain) and because of possible crystal packing effects. Even so, conformational changes unique to the LSD binding site may underlie some of its most interesting pharmacological properties.
So what does LSD look like when bound to the receptor? As in the endogenous agonist 5-HT, LSD contains a tryptamine moiety but also features a diethylamide substituent known to be important for its psychedelic properties. The tryptamine moiety sits in the endogenous agonist binding site (the orthosteric pocket) and is anchored via a salt bridge between its nitrogen and a conserved aspartate side chain. The ergoline ring system of LSD is further stabilized by hydrophobic interactions with the receptor core. Interestingly, the tryptamine core of LSD is rotated upward in the pocket relative to that of ergotamide, which has a much larger amide substituent. The diethylamide group of LSD binds with its ethyl moieties in a stereospecific manner reminiscent of the legs of a bicyclist. The authors go on to show, by using chemical analogs, that if the ethyl ''legs'' are constrained in a configuration opposite to that observed in the complex, then there is a dramatic loss of arrestin recruitment, but not of G protein coupling. These findings are consistent with a previous study in which the spatial configuration of the diethylamide legs was shown to be important for their potency in rats (Nichols et al., 2002) . Together, the data strongly indicate that stereoselective binding of LSD to the receptor is critical for its ability to preferentially recruit arrestin and, ultimately, for its psychedelic properties in animals.
An LSD-triggered acid trip lasts 6-15 hr, even though its clearance from the body is much faster (t 1/2 of around 3.6 hr) (Dolder et al., 2015) . So what underlies the prolonged effect of LSD? Wacker et al.
(2017) provide a potential molecular explanation: an extracellular loop of the HT 2B receptor (and likely of HT 2A ) forms a lid covering the ligand-binding site, thereby slowing the dissociation of LSD from the receptor. Residues in the lid directly interact with LSD, and disrupting this interaction by site-directed mutagenesis results in 103 faster off-rate and, hence, 103 shorter residency time of LSD. Remarkably, a mutant that reduces interactions between the lid and LSD also attenuates arrestin recruitment while leaving the activation of G protein signaling intact, supporting the idea that specific contacts between the lid and LSD are critical for stabilizing the receptor in a conformational state that promotes the psychedelic effects of the drug.
An important caveat is that, although LSD preferentially promotes the recruitment of arrestin relative to compounds like lysergamide, not all hallucinogenic drugs acting at 5HT receptors are necessarily dependent on arrestin (Schmid et al., 2008) . In fact, 5-HT differs from closely related psychoactive analogs by its ability to recruit b-arrestin 2 (Schmid and Bohn, 2010) . Thus, the molecular bases underlying a complex process such as hallucination are likely to be ligand and context dependent, and the role of arrestin itself in the LSD-mediated psychedelic process merits deeper investigation. The work reported by Wacker et al. (2017) is nonetheless important, not only because of its historical interest, but also because it provides a roadmap for the rational design of drugs that are more biased toward desirable outcomes. In the case of LSD, this would entail the synthesis of variants that retain therapeutic benefit without psychedelic effects, but it remains to be seen if these can truly be separated. It wasn't long ago that, except for ribosomes and icosahedral virus particles, single-particle electron cryomicroscopy (cryo-EM) was mostly limited to producing 3D maps of protein structure at worse than 10 Å resolution. At these resolutions, the technique was useful for determining how protein subunits of macromolecular assemblies fit together, but few structural features of individual proteins could be discerned. Resolving a helices requires around 7 Å resolution, while distinguishing b strands needs better than 5 Å resolution. The situation changed recently due to the introduction of a new type of electron microscope camera with a much higher detective quantum efficiency (DQE) than earlier detectors and the ability to record movies rather than integrated exposures. A higher DQE means that more signal is detected for the electrons that scatter from the specimen, and the positions where electrons strike the camera sensor are recorded with higher accuracy. Movie acquisition allows image analysis software to account for some of the beam-induced motion and radiation damage that occurs when frozen-hydrated specimens are exposed to the highly energetic electron beam of the microscope. While early cryo-EM work was limited to proteins more than a few hundred kDa in mass, the DQE of the new cameras has allowed smaller structures to be studied. As a result, there has been a deluge of structures at 3.0-4.5 Å resolution, not sufficient to see the orientations of small amino acid side chains but good enough for building reliable polypeptide backbone models and determining orientations of large side chains. One of these recent structures was the closed state of Slo2.2 (Hite et al., 2015) , a neuronal Na + -activated K + channel that is the subject of the paper being highlighted here. Cryo-EM seems poised to overtake X-ray crystallography as the go-to technique for determining the structures of macromolecules. However, cryo-EM can do more than just solve structures. The ability to computationally separate different states of a molecule allows for exploration of the different conformations of proteins that are trapped when cryo-EM specimens are frozen. Computationally separating the different species in the specimen is known as 3D classification. This technique has allowed for observation of numerous conformations of ribosomes (Fernandez et al., 2013) , rotational states of rotary enzymes (Zhao et al., 2015) , and detecting mobility for individual a helices thought to be important for enzyme mechanism (Bai et al., 2015) . Ligand-dependent channels are ideal candidates for this sort of analysis. For Slo2.2, Na + binding induces opening of the protein's K + -selective channel pore. Like most channels, and as revealed by electrophysiological measurements, Slo2.2 flickers between closed and opened states, with an increased probability of adopting the open state as the concentration of Na + increases ( Figure 1A) .
The paper in this issue of Cell by Hite and MacKinnon is remarkable for two reasons. First, the authors determine the
